Patents by Inventor Yunmei Wang

Yunmei Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250095353
    Abstract: The present application discloses a method for detecting cigarette appearance defects based on variational Bayesian inference. In a cigarette appearance defect detection scenario, in order to solve the problem that a current point estimation-based machine learning algorithm leads to an overconfidence decision in a data scarcity area, the present application proposes a variational inference-based Bayesian method to improve a SSD backbone network, preferably including calculating a real posterior probability by the variational inference method, replacing a point estimation mechanism of a convolution layer weight in the original backbone network by using a form of probability distribution, then detecting the improved extracted features by an SSD target detection algorithm, and furthermore, accurately determining whether the appearance of the cigarette is defective and the type and location of the defect.
    Type: Application
    Filed: February 24, 2023
    Publication date: March 20, 2025
    Inventors: Xianzhou LV, Lin Qi, Yuxiang CUI, Dan LIN, Faqing LV, Liang CHENG, Lu YANG, Bing LIU, Meilin YI, Yunmei WANG, Yuedong QIAN, Shichae WU, Yunyu GONG
  • Publication number: 20220403014
    Abstract: A method of inhibiting hypercoagulation and/or thrombosis in a subject having or at risk of hypercoagulation or thrombosis includes administering to the subject an amount of a composition effective to inhibit MRP-8/14 and/or MRP-14 binding to platelet CD36 and inhibit hypercoagulation and/or thrombosis in the subject.
    Type: Application
    Filed: June 22, 2022
    Publication date: December 22, 2022
    Inventors: Daniel I. Simon, Yunmei Wang, Kevin Croce, Matthew Bilodeau
  • Patent number: 10385321
    Abstract: A peptide for targeting MRP-14 has an amino acid sequence at least 80% identical to amino acid sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 9, and SEQ ID NO: 10.
    Type: Grant
    Filed: June 6, 2017
    Date of Patent: August 20, 2019
    Assignee: CASE WESTERN RESERVE UNIVERSITY
    Inventors: Nicole F. Steinmetz, Amy M. Wen, Daniel Simon, Yunmei Wang